Skip to content

EchoGo(horizontal) blue text

 

AI-Powered Heart Disease Detection and Prediction

 

Zero variability. Improved risk stratification. 

ezgif.com-gif-maker (7)

 

FDA-cleared and award winning for better CVD and heart failure detection

Ultromics uses patented, regulatory approved AI technology to calculate the analysis of echocardiograms, incorporating 230+ measurements, helping clinicians make more informed decisions when diagnosing heart disease. 

Trusted by world-renowned healthcare sites

demo-page-benefits-clinical-long-1

Smarter analysis with over 230 measurements

Take advantage of even more measurements, such as Global Longitudinal Strain,  without the extra time analyzing or training. 

  • Left Ventricle Ejection Fraction and Volumes

  • Global Longitudinal Strain and Regional Strain

  • HFpEF

High quality, zero variability interpretation every time

Level up your reporting to a fully managed service that uses ground-breaking, accurate AI so you can provide the best level of care.   

  • High quality interpretation for accurate decision-making.

  • Removes manual subjectivity and variability that exists on-premise.

  • Reliable reports that trainees and non-experts can use. 

Accelerate time to treatment

Since EchoGo takes care of analysis, there is opportunity to increase direct patient care and drive up echo volume.

  • Automates and interprets scans immediately.

  • Automatically takes scans from PACS throughout the day.

  • Reports are appended to studies for you to view within 15 minutes.

  • Sophisticated yet simple report to give guidance to non-experts and primary care.

 

Outsourcing your reporting can also drive operational value

demo-page-benefits-IT

"A complex pathway of symptoms, circumstances and features means that it is not always easy to correctly identify Coronary Artery Disease (CAD) on first visit”, said Dr. David Ripley, the Trust’s director of research and development and a consultant cardiologist. “We are using Ultromics’ Artificial intelligence platform, EchoGo, in our Echocardiography exams to analyse CAD patients and detect features that would have been impossible to detect using traditional software. EchoGo has the potential to improve the diagnostic accuracy of predicting coronary artery disease within our Trust"

Dr David Ripley,

Northumbria NHS Trust R&D Director

Try EchoGo for yourself using your own studies

About us

Ready to experience the power of EchoGo?

Schedule a consultation with our clinical experts.

Contact Us